GE Healthcare's AngioViz Vascular Vision Software Receives FDA Clearance

GE Healthcare GE today announced the FDA clearance of AngioViz, an application that gives doctors a new visualization of vascular flow on a single image to help them make important decisions during complex interventional radiology procedures. AngioViz yields its information from Digital Subtraction Angiography, a technique commonly used to show the vascular anatomy.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsFDAIndustrial ConglomeratesIndustrials
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!